Operation Alone for Resectable Pancreatic Adenocarcinoma: Should We Operate if Multimodal Treatment Is Off the Table?
This national study of patients with early-stage PDAC affirms that surgical resection, in the absence of multimodal therapy, is associated with improved outcomes compared with no resection. However, the association with improved survival is clinically annulled in the absence of a negative-margin resection.
Authors
- Peter J. Fagenholz (ORCID: https://orcid.org/0000-0002-7787-0317)
- Carlos F. Fernandez-del Castillo (ORCID: https://orcid.org/0000-0001-5975-7225)
- Motaz Qadan (ORCID: https://orcid.org/0000-0001-6951-8308)
- Keith D. Lillemoe (ORCID: https://orcid.org/0009-0004-5057-3875)
- Roi Anteby (ORCID: https://orcid.org/0000-0003-0567-0655)
- William V. Kastrinakis
Institutions
- Newton Wellesley Hospital (US)
- Salem Hospital (US)
- Massachusetts General Hospital (US)
Publication Details
- Journal
- Journal of the American College of Surgeons
- Published
- 2025-05-30
- DOI
- https://doi.org/10.1097/xcs.0000000000001464
- Citations
- 1
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 1.05